Baxter International Inc Market Cap ($13.26 Billion)
Market Cap & Net Worth: Baxter International Inc (BAX)
Baxter International Inc market cap. Baxter International Inc (NYSE:BAX) has a market capitalization of $13.26 Billion ($13.26 Billion) as of November 7, 2026. Listed on the NYSE stock exchange, this USA-based company holds position #1759 globally and #676 in its home market, demonstrating a 0.75% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Baxter International Inc's stock price $25.65 by its total outstanding shares 516995999 (517.00 Million). Also see Baxter International Inc operating cash flow efficiency for how efficiently the company converts equity into cash flow.
Baxter International Inc Market Cap History (2015–2026)
Baxter International Inc market cap history from 2015 to 2026. Data shows change from $17.09 Billion to $13.26 Billion (-1.22% CAGR). Check BAX stock price for real-time trading data and today's change.
Index Memberships
Baxter International Inc is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
S&P 500 Index
GSPC
|
$60.15 Trillion | 0.03% | #425 of 503 |
Weight: Baxter International Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Baxter International Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Baxter International Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Baxter International Inc annual equity growth to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.88x
Baxter International Inc's market cap is 0.88 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $20.09 Billion | $10.16 Billion | $4.96 Billion | 1.98x | 4.05x |
| 2017 | $29.60 Billion | $10.58 Billion | $602.00 Million | 2.80x | 49.16x |
| 2018 | $30.45 Billion | $11.10 Billion | $1.55 Billion | 2.74x | 19.70x |
| 2019 | $39.10 Billion | $11.36 Billion | $1.00 Billion | 3.44x | 39.06x |
| 2020 | $37.95 Billion | $11.67 Billion | $1.10 Billion | 3.25x | 34.44x |
| 2021 | $41.17 Billion | $12.15 Billion | $1.28 Billion | 3.39x | 32.07x |
| 2022 | $24.88 Billion | $10.06 Billion | -$2.43 Billion | 2.47x | N/A |
| 2023 | $19.43 Billion | $10.36 Billion | $2.66 Billion | 1.88x | 7.31x |
| 2024 | $15.08 Billion | $10.64 Billion | -$649.00 Million | 1.42x | N/A |
| 2025 | $9.88 Billion | $11.24 Billion | -$957.00 Million | 0.88x | N/A |
Competitor Companies of BAX by Market Capitalization
Companies near Baxter International Inc in the global market cap rankings as of November 7, 2026. Also see BAX asset base for a full breakdown of the balance sheet.
Key companies related to Baxter International Inc by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #170 globally with a market cap of $132.26 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #237 globally with a market cap of $103.91 Billion USD ( €88.88 Billion EUR).
- ESSILORLUXOTTICA 1/2/O.N. (F:ESLC): Ranked #417 globally with a market cap of $67.43 Billion USD ( €57.68 Billion EUR).
- HOYA CORP. ADR/ 1 O.N. (F:HYB0): Ranked #533 globally with a market cap of $50.37 Billion USD ( €43.09 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #170 | Intuitive Surgical Inc | NASDAQ:ISRG | $132.26 Billion | $468.52 |
| #237 | EssilorLuxottica S. A. | PA:EL | $103.91 Billion | €191.95 |
| #417 | ESSILORLUXOTTICA 1/2/O.N. | F:ESLC | $67.43 Billion | €94.50 |
| #533 | HOYA CORP. ADR/ 1 O.N. | F:HYB0 | $50.37 Billion | €150.00 |
Market Capitalization of Baxter International Inc (2015–2026)
Market capitalization of Baxter International Inc from 2015 to today. Between 2015 and today, Baxter International Inc's market cap moved from $17.09 Billion to $ 13.26 Billion, with a yearly change of -1.22%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $13.26 Billion | +34.22% |
| 2025 | $9.88 Billion | -34.47% |
| 2024 | $15.08 Billion | -22.40% |
| 2023 | $19.43 Billion | -21.91% |
| 2022 | $24.88 Billion | -39.58% |
| 2021 | $41.17 Billion | +8.48% |
| 2020 | $37.95 Billion | -2.93% |
| 2019 | $39.10 Billion | +28.40% |
| 2018 | $30.45 Billion | +2.89% |
| 2017 | $29.60 Billion | +47.30% |
| 2016 | $20.09 Billion | +17.58% |
| 2015 | $17.09 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 6th, 2026 the market cap of Baxter International Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $13.26 Billion USD |
| MoneyControl | $13.26 Billion USD |
| MarketWatch | $13.26 Billion USD |
| marketcap.company | $13.26 Billion USD |
| Reuters | $13.26 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Baxter International Inc
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable p… Read more